- Home
- Latest
- By speciality
- Biology
- Bone
- Brain and nervous system
- Breast
- Colorectal and gastrointestinal
- Community
- Diagnostics
- Drug development
- Epidemiology and prevention
- Haematology oncology
- Head and neck
- Hepatobiliary pancreatic
- Lung and pleura
- Melanoma and skin
- Ovary and gynaecology
- Paediatric
- Prostate and urology
- Psycho social
- Radiotherapy
- Sarcomas
- Surgery
- Other
- By congress
- By continent
- Latest technologies
- Most viewed
- Archive
- Contact us
- FAQ's
- Register
Australasia, Breast, SABCS 2008
Flash player required
You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.
Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: Letrozole vs tamoxifen
BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Alan Coates, M.D., clinical professor in the School of Public Health at the University of Sydney in Australia, speaking at the 2008 San Antonio Breast Cancer Symposium
Specialities
- Biology (58)
- Bone (16)
- Brain and nervous system (14)
- Breast (143)
- Colorectal and gastrointestinal (32)
- Community (61)
- Diagnostics (27)
- Drug development (49)
- Epidemiology and prevention (42)
- Haematology oncology (39)
- Head and neck (17)
- Hepatobiliary pancreatic (15)
- Lung and pleura (30)
- Melanoma and skin (22)
- Ovary and gynaecology (29)
- Paediatric (17)
- Prostate and urology (32)
- Psycho social (19)
- Radiotherapy (18)
- Sarcomas (13)
- Surgery (24)
Content is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
Comments on this video Report unsuitable comment
No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.
Add a comment